Literature DB >> 23778161

Multiple sclerosis, blood flow, and CSF circulation.

Jens Wuerfel1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23778161      PMCID： PMC3764394          DOI： 10.1038/jcbfm.2013.96

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN： 0271-678X            Impact factor:   6.200


× No keyword cloud information.
  6 in total

1.  Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study.

Authors:  Jens Wuerfel; Judith Bellmann-Strobl; Peter Brunecker; Orhan Aktas; Henry McFarland; Arno Villringer; Frauke Zipp
Journal:  Brain       Date:  2003-10-21       Impact factor: 13.501

Review 2.  Immunology of multiple sclerosis.

Authors:  Mireia Sospedra; Roland Martin
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.

Authors:  Souraya ElSankari; Olivier Balédent; Vincent van Pesch; Christian Sindic; Quentin de Broqueville; Thierry Duprez
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-19       Impact factor: 6.200

4.  Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.

Authors:  Tim Sinnecker; Jan Dörr; Caspar F Pfueller; Lutz Harms; Klemens Ruprecht; Sven Jarius; Wolfgang Brück; Thoralf Niendorf; Jens Wuerfel; Friedemann Paul
Journal:  Neurology       Date:  2012-08-01       Impact factor: 9.910

Review 5.  The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis.

Authors:  Paolo Zamboni
Journal:  J R Soc Med       Date:  2006-11       Impact factor: 18.000

Review 6.  What went wrong? The flawed concept of cerebrospinal venous insufficiency.

Authors:  José M Valdueza; Florian Doepp; Stephan J Schreiber; Bob W van Oosten; Klaus Schmierer; Friedemann Paul; Mike P Wattjes
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-27       Impact factor: 6.200
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.